Effect of high parity on occurrence of anemia in pregnancy: a cohort study.
BACKGROUND
Studies that explore the controversial association between parity and anaemia-in-pregnancy (AIP) were often hampered by not distinguishing incident cases caused by pregnancy from prevalent cases complicated by pregnancy. The authors' aim in conducting this study was to overcome this methodological concern.


METHODS
A retrospective cohort study was conducted in Oman on 1939 pregnancies among 479 parous female participants with available pregnancy records in a community trial. We collected information from participants, the community trial, and health records of each pregnancy. Throughout the follow-up period, we enumerated 684 AIP cases of which 289 (42.2%) were incident cases. High parity (HP, ≥ 5 pregnancies) accounted for 48.7% of total pregnancies. Two sets of regression analyses were conducted: the first restricted to incident cases only, and the second inclusive of all cases. The relation with parity as a dichotomy and as multiple categories was examined for each set; multi-level logistic regression (MLLR) was employed to produce adjusted models.


RESULTS
In the fully adjusted MLLR models that were restricted to incident cases, women with HP pregnancies had a higher risk of AIP compared to those who had had fewer pregnancies (Risk Ratio, RR = 2.92; 95% CI 2.02, 4.59); the AIP risk increased in a dose-response fashion over multiple categories of parity. In the fully adjusted MLLR models that included all cases, the association disappeared (RR = 1.11; 95% CI 0.91, 1.18) and the dose-response pattern flattened.


CONCLUSIONS
This study shows the importance of specifying which cases of AIP are incident and provides supportive evidence for a causal relation between parity and occurrence of incidental AIP.
Department of Family Medicine and Public Health, College of Medicine and Health Sciences, Sultan Qaboos University, Oman. ymfarsi@gmail.com
Yahya M
YM
Al-Farsi
Daniel R
DR
Brooks
Martha M
MM
Werler
Howard J
HJ
Cabral
Mohammed A
MA
Al-Shafei
Henk C
HC
Wallenburg
D000293:Adolescent; D000328:Adult; D000740:Anemia / Q000453:epidemiology* / Q000209:etiology; D005260:Female; D006801:Humans; D015994:Incidence; D009850:Oman / Q000453:epidemiology; D010298:Parity; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000453:epidemiology* / Q000209:etiology; D015995:Prevalence; D012044:Regression Analysis; D012189:Retrospective Studies; D012306:Risk; D055815:Young Adult
Acta Obstet Gynecol Scand. 1987;66(1):53-6
3604593
BJOG. 2002 Mar;109(3):249-53
11950178
Int J Gynaecol Obstet. 1993 Apr;41(1):17-22
8098289
Int J Gynaecol Obstet. 1991 Sep;36(1):13-6
1683295
Int J Gynaecol Obstet. 1992 Apr;37(4):259-64
1350541
Asia Pac J Clin Nutr. 2007;16(3):527-36
17704035
Obstet Gynecol. 1961 Dec;18:719-25
13895639
Eur J Public Health. 2006 Apr;16(2):168-72
16303866
Obstet Gynecol. 2008 Jul;112(1):201-7
18591330
Eur J Obstet Gynecol Reprod Biol. 2002 Feb 10;101(1):22-5
11803095
Arch Gynecol Obstet. 2001 Jan;264(4):194-8
11205707
Am J Clin Nutr. 2005 May;81(5):1218S-1222S
15883455
Birth. 2005 Mar;32(1):45-59
15725205
Am J Obstet Gynecol. 2002 Feb;186(2):274-8
11854649
Int J Gynaecol Obstet. 1980 Sep-Oct;18(2):144-6
6108255
Asia Oceania J Obstet Gynaecol. 1994 Mar;20(1):67-72
8172530
Med J Aust. 2003 Sep 15;179(6):294-6
12964911
Am J Obstet Gynecol. 1995 Feb;172(2 Pt 1):683-6
7856706
Am J Obstet Gynecol. 1954 Feb;67(2):253-62
13124397